Latest Commercial Milestones News

Page 17 of 18
InteliCare Holdings has secured a binding agreement to trial its AI-driven platform at mecwacare’s Trescowthick Centre, marking a significant step in its commercialisation strategy within Victoria’s aged care sector.
Ada Torres
Ada Torres
29 Apr 2025
Simble Solutions reported a 39% rise in customer cash receipts for Q1 FY25 and strengthened its market position through strategic partnerships and renewable energy initiatives.
Maxwell Dee
Maxwell Dee
29 Apr 2025
Algorae Pharmaceuticals reports significant progress in its AI-driven drug discovery platform, unveiling 24 novel oncology targets and appointing a seasoned Chief Commercial Officer to bolster market readiness.
Ada Torres
Ada Torres
29 Apr 2025
Sprintex Limited has advanced its commercial and technological milestones with major European and Indian orders, breakthrough energy efficiency validation, and a successful A$3.25 million equity raise, positioning the company for accelerated growth.
Victor Sage
Victor Sage
29 Apr 2025
Vitrafy Life Sciences reported strong Q3 FY2025 progress, including a successful US Army blood platelet study, a $4.8 million government grant, and strategic US market expansion.
Ada Torres
Ada Torres
29 Apr 2025
Artrya Limited has secured A$15 million through a two-tranche placement aimed at accelerating regulatory approvals and commercial rollout of its Salix® coronary artery disease diagnostic software in the US.
Ada Torres
Ada Torres
14 Feb 2025
AVITA Medical reported a strong 30% increase in Q4 2024 commercial revenue and amended its credit agreement with OrbiMed to adjust revenue covenants through 2026. The company is poised for significant growth with new product rollouts and expects profitability by year-end 2025.
Ada Torres
Ada Torres
14 Feb 2025
Micro-X Limited has initiated a $2.7 million retail entitlement offer as part of a broader $6 million capital raising, supporting its strategic pivot towards medical imaging technologies and strengthening its balance sheet.
Victor Sage
Victor Sage
13 Feb 2025
Telix Pharmaceuticals has gained UK MHRA approval for Illuccix, its advanced prostate cancer PET imaging agent, promising to alleviate supply shortages and improve diagnostic accuracy across the UK.
Ada Torres
Ada Torres
13 Feb 2025
Memphasys has completed the final patient visit in its Felix™ clinical trial, with data lock expected within two weeks and preliminary results slated for early March 2025. This milestone paves the way for CE Mark submission and imminent commercialisation in Europe.
Ada Torres
Ada Torres
11 Feb 2025
Gyder Surgical, backed by Hydrix Ventures, has secured FDA 510(k) clearance for its innovative GYDER Hip System, opening the door to the lucrative U.S. market and increasing Hydrix’s investment value.
Ada Torres
Ada Torres
10 Feb 2025
Micro-X has raised $3.3 million through a placement and institutional entitlement offer, reinforcing its strategic shift towards medical imaging technologies. A retail entitlement offer aiming to raise an additional $2.7 million will open shortly, supporting the company’s development of mobile X-ray and CT products.
Ada Torres
Ada Torres
10 Feb 2025